Psivida Q1 Profit Tops Estimates - Quick Facts

(RTTNews) - pSivida Corp. (PSDV) Friday reported profit for the first quarter, compared with a loss last year, as revenues surged following the recognition of the $25.0 million milestone earned upon FDA approval of ILUVIEN. Net income for the quarter was $20.6 million or $0.67 per share, while the company posted a net loss of $3.7 million or $0.14 per share for the prior year period. Analysts polled by Thomson Reuters expected the company to report loss of $0.12 per share for the quarter. Analysts' estimates typically exclude special items. Quarterly revenues soared to $25.3 million from $597 thousand a year ago, while analysts were looking for revenues of $650 thousand.